CompletedPHASE1, PHASE2NCT00657618

Use of Sodium Stibogluconate as a Treatment for Leishmaniasis

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
U.S. Army Medical Research and Development Command
Principal Investigator
Roseanne Ressner, MD
Walter Reed National Military Medical Center, Infectious Disease
Intervention
Sodium Stibogluconate (SSG)(drug)
Enrollment
77 enrolled
Eligibility
All sexes
Timeline
2004 – 2015

Study locations (1)

Collaborators

Walter Reed Army Medical Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00657618 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials